Last quarter (Q ), Cincor Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Cincor Pharma's net income was $-20.98M. See Cincor Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20
Total Revenue	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-
Gross Profit	-	-	-
Operating Expense	$ 82.53M	$ 42.51M	$ 21.13M
Operating Income	$ -82.53M	$ -42.51M	$ -21.13M
Net Non Operating Interest Income Expense	$ 1.61M	$ 21.64K	$ 36.73K
Other Income Expense	$ -7.17M	$ -7.88M	$ -1.21M
Pretax Income	$ -88.09M	$ -50.37M	$ -22.30M
Tax Provision	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-
Net Income Common Stockholders	$ -88.09M	$ -50.37M	$ -22.30M
Basic EPS	$ -2.40	$ -1.42	$ -0.95
Diluted EPS	$ -2.40	$ -1.42	$ -0.95
Basic Average Shares	$ 147.37M	$ 35.42M	$ 23.49M
Diluted Average Shares	$ 147.37M	$ 35.42M	$ 23.49M
Dividend Per Share	-	-	-
Total Operating Income As Reported	-	-	-
Reported Normalized Basic E P S	-	-	-
Reported Normalized Diluted E P S	-	-	-
Rent Expense Supplemental	-	-	-
Total Expenses	$ 82.53M	$ 42.51M	$ 21.13M
Net Income From Continuing And Discontinued Operation	$ -88.09M	$ -50.37M	$ -22.30M
Normalized Income	$ -80.92M	$ -42.49M	$ -21.09M
Interest Expense	-	-	-
EBIT	$ -82.53M	$ -42.51M	$ -21.13M
EBITDA	$ -82.53M	$ -42.51M	$ -21.13M

Currency in USD

Cincor Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing